BMS 186318
BMS 186318 is an HIV protease inhibitor. BMS 186318 exhibits better anti-HIV efficacy when used in combination with reverse transcriptase inhibitors such as Stavudine (HY-B0116) and other protease inhibitors such as Saquinavir (HY-17007). BMS 186318 can be used in antiviral research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 161302-40-5
- Formule: C36H54N4O9
- Masse moléculaire:686.84
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CEM-SS | ED50 |
0.1 μM
Compound: 10n
|
Inhibitory activity against HIV-1 virus replication as determined by an XTT endpoint by 50%
Inhibitory activity against HIV-1 virus replication as determined by an XTT endpoint by 50%
|
[PMID: 8642558] |
| H9 | CC50 |
>100 μM
Compound: 10n
|
Inhibitory activity against human T cell lymphoma (H9) growth by 50 %.
Inhibitory activity against human T cell lymphoma (H9) growth by 50 %.
|
[PMID: 8642558] |
Chemical Information
-
CAS No. 161302-40-5
-
Masse moléculaire 686.84
-
Formule C36H54N4O9
-
SMILES
CC(C)(C)OC(N[C@@H](CC1=CC=CC=C1)[C@H](O)CNC[C@@H](O)[C@H](CC2=CC=C(OCC(N3CCOCC3)=O)C=C2)NC(OC(C)(C)C)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)